Research Paper Volume 10, Issue 10 pp 2570—2584

CLCA4 inhibits cell proliferation and invasion of hepatocellular carcinoma by suppressing epithelial-mesenchymal transition via PI3K/AKT signaling

Figure 3. Combined value of CLCA4 and serum AFP identify different risks of HCC death and recurrence. The associations of CLCA4/AFP co-expression with Overall survival (log-rank P < 0.001) (A) and Time to recurrence (log-rank P < 0.001) (B) in 186 HCC patients.